Gga-miR-9* inhibits IFN production in antiviral innate immunity by targeting interferon regulatory factor 2 to promote IBDV replication

Veterinary Microbiology

Volumn 178, Issue 1-2, 2015, Pages 41-49

  Ouyang, Wei ^a,b,c   Wang, Yong shan ^b,c   Du, Xi ning ^b   Liu, Hua jie ^a,b   Zhang, Hai bin ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c YANGZHOU UNIVERSITY   (China)

Author keywords

Gga miR 9*; Infectious bursal disease virus (IBDV); MiRNA; SiRNA

Indexed keywords

GGA MICRORNA 9; INTERFERON; INTERFERON REGULATORY FACTOR 2; MESSENGER RNA; MICRORNA 9; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; LUCIFERASE; MICRORNA;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING SITE; BIOINFORMATICS; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; GERMFREE CHICKEN; INFECTIOUS BURSAL DISEASE; INFECTIOUS BURSAL DISEASE VIRUS; INNATE IMMUNITY; INTERFERON PRODUCTION; LUCIFERASE ASSAY; NONHUMAN; PROTEIN EXPRESSION; RNA ANALYSIS; RNA INTERFERENCE; UPREGULATION; VIRUS REPLICATION; VIRUS TITRATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIRD DISEASE; BIRNAVIRUS INFECTION; CHICKEN; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PHYSIOLOGY; VETERINARY; VIROLOGY;

GALLUS GALLUS; INFECTIOUS BURSAL DISEASE VIRUS;

ANIMALS; ANTIVIRAL AGENTS; BIRNAVIRIDAE INFECTIONS; CHICKENS; GENE KNOCKDOWN TECHNIQUES; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; INFECTIOUS BURSAL DISEASE VIRUS; INTERFERON REGULATORY FACTOR-2; INTERFERON TYPE I; LUCIFERASES; MICRORNAS; POULTRY DISEASES; VIRUS REPLICATION;

EID: 84930479821     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2015.04.023     Document Type: Article

References (45)

1. Bayliss C., Peters R., Cook J.K., Reece R., Howes K., Binns M., Boursnell M. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch. Virol. 1991, 120:193-205.
2. Brandt M., Yao K., Liu M., Heckert R.A., Vakharia V.N. Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus. J. Virol. 2001, 75:11974-11982.
3. Bublot M., Pritchard N., Le Gros F.-X., Goutebroze S. Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody. J. Comp. Pathol. 2007, 137:S81-S84.
4. Chang H.C., Lin T.L., Wu C.C. DNA-mediated vaccination against infectious bursal disease in chickens. Vaccine 2001, 20:328-335.
5. Chendrimada T.P., Finn K.J., Ji X., Baillat D., Gregory R.I., Liebhaber S.A., Pasquinelli A.E., Shiekhattar R. MicroRNA silencing through RISC recruitment of eIF6. Nature 2007, 447:823-828.
6. Delaloy C., Liu L., Lee J.-A., Su H., Shen F., Yang G.-Y., Young W.L., Ivey K.N., Gao F.-B. MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell 2010, 6:323-335.
7. Dolz R., Majo N., Ordóñez G., Porta R. Viral genotyping of infectious bursal disease viruses isolated from the 2002 acute outbreak in Spain and comparison with previous isolates. Avian Dis. 2005, 49:332-339.
8. Eldaghayes I., Rothwell L., Williams A., Withers D., Balu S., Davison F., Kaiser P. Infectious bursal disease virus: strains that differ in virulence differentially modulate the innate immune response to infection in the chicken bursa. Viral Immunol. 2006, 19:83-91.
9. Engels B.M., Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006, 25:6163-6169.
10. Escaffre O., Le Nouën C., Amelot M., Ambroggio X., Ogden K.M., Guionie O., Toquin D., Müller H., Islam M.R., Eterradossi N. Both genome segments contribute to the pathogenicity of very virulent infectious bursal disease virus. J. Virol. 2013, 87:2767-2780.
11. Garzon R., Calin G.A., Croce C.M. MicroRNAs in cancer. Annu. Rev. Med. 2009, 60:167-179.
12. Huang Z., Elankumaran S., Yunus A.S., Samal S.K. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J. Virol. 2004, 78:10054-10063.
13. Ingrao F., Rauw F., Lambrecht B., van den Berg T. Infectious Bursal disease: a complex host-pathogen interaction. Dev. Comp. Immunol 2013, 41:429-438.
14. Jackwood D.J. Multivalent virus-like-particle vaccine protects against classic and variant infectious bursal disease viruses. Avian Dis. 2012, 57:41-50.
15. Jakka P., Reddy Y., Kirubaharan J., Chandran N.D. Evaluation of immune responses by live infectious bursal disease vaccines to avoid vaccination failures. Eur. J. Microbiol. Immunol. 2014, 4:123-127.
16. Kumar S. DNA vaccine against infectious bursal disease virus: still more to explore. Vet. Microbiol. 2015, 175:389-390.
17. Lee C.-C., Wu C.C., Lin T.L. Chicken melanoma differentiation-associated gene 5 (MDA5) recognizes infectious bursal disease virus infection and triggers MDA5-related innate immunity. Arch. Virol. 2014, 1-16.
18. Luo D.D., Luo Y.P., Peng J., Li S.G. Molecular evolution of miRNA-9 gene family and prediction of their target genes. Chin. J. Cell Biol. 2011, 33:510-519.
19. Mahgoub H.A. An overview of infectious bursal disease. Arch. Virol. 2012, 157:2047-2057.
20. Malmgaard L. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 2004, 24:439-454.
21. Massirer K.B., Pasquinelli A.E. The evolving role of microRNAs in animal gene expression. Bioessays 2006, 28:449-452.
22. Miyoshi K., Okada T.N., Siomi H., Siomi M.C. Characterization of the miRNA-RISC loading complex and miRNA-RISC formed in the drosophila miRNA pathway. RNA 2009, 15:1282-1291.
23. Ouyang W., Ma J.R., Wang Y.Q., Qin L.T., Jiang J.Y., Fan H.J., Wang X.M., Wang Y.S. Reduction of infectious bursal disease virus replication by shRNAs targeting the VP1 and VP2 genes driven by chicken U6 promoter. Vet. Microbiol. 2013, 162:44-52.
24. Packer A.N., Xing Y., Harper S.Q., Jones L., Davidson B.L. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J. Neurosci. 2008, 28:14341-14346.
25. Perozo F., Villegas P., Fernandez R., Cruz J., Pritchard N. Efficacy of single dose recombinant herpesvirus of turkey infectious bursal disease virus (IBDV) vaccination against a variant IBDV strain. Avian Dis. 2009, 53:624-628.
26. Plaisance V., Abderrahmani A., Perret-Menoud V., Jacquemin P., Lemaigre F., Regazzi R. MicroRNA-9 controls the expression of granuphilin/Slp4 and the secretory response of insulin-producing cells. J. Biol. Chem. 2006, 281:26932-26942.
27. Qi X., Chen Y., Ren X., Zhang L., Gao L., Wang N., Qin L., Wang Y., Gao Y., Wang X. A reassortment vaccine candidate as the improved formulation to induce protection against very virulent infectious bursal disease virus. Vaccine 2014, 32:1436-1443.
28. Rong J., Cheng T., Liu X., Jiang T., Gu H., Zou G. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine 2005, 23:4844-4851.
29. Rong J., Jiang T., Cheng T., Shen M., Du Y., Li S., Wang S., Xu B., Fan G. Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens. Vaccine 2007, 25:7900-7908.
30. Rouyez M.-C., Lestingi M., Charon M., Fichelson S., Buzyn A., Dusanter-Fourt I. IFN regulatory factor-2 cooperates with STAT1 to regulate transporter associated with antigen processing-1 promoter activity. J. Immunol. 2005, 174:3948-3958.
31. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14:778-809.
32. Sedighzadeh S.S., Shamsara M., Shahpiri A. Fusion protein strategy to increase expression and solubility of hypervariable region of VP2 protein of infectious bursal disease virus in Escherichia coli. Protein J. 2012, 31:580-584.
33. Shaw I., Davison T. Protection from IBDV-induced bursal damage by a recombinant fowlpox vaccine, fpIBD1, is dependent on the titre of challenge virus and chicken genotype. Vaccine 2000, 18:3230-3241.
34. Taghavian O., Spiegel H., Hauck R., Hafez H.M., Fischer R., Schillberg S. Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris. PLoS One 2013, 8:e83210.
35. Taki S., Nakajima S., Ichikawa E., Saito T., Hida S. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J. Immunol. 2005, 174:6005-6012.
36. Tsukamoto K., Kojima C., Komori Y., Tanimura N., Mase M., Yamaguchi S. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology 1999, 257:352-362.
37. Tsukamoto K., Saito S., Saeki S., Sato T., Tanimura N., Isobe T., Mase M., Imada T., Yuasa N., Yamaguchi S. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J. Virol. 2002, 76:5637-5645.
38. Wang S., Ouyang W., Liu J., He W., Yu S.-Q., Zhang H.-B., Fan J., Lu C.-P. Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV. Vaccine 2012, 30:2125-2130.
39. Wang Y.-S., Ouyang W., Pan Q.-X., Wang X.-L., Xia X.-X., Bi Z.-W., Wang Y.-Q., Wang X.-M. Overexpression of microRNA gga-miR-21 in chicken fibroblasts suppresses replication of infectious bursal disease virus through inhibiting VP1 translation. Antivir. Res. 2013, 100:196-201.
40. Wu P.C., Su H.Y., Lee L.H., Lin D.T., Yen P.C., Liu H.J. Secreted expression of the VP2 protein of very virulent infectious bursal disease virus in the methylotrophic yeast Pichia pastoris. J. Virol. Methods 2005, 123:221-225.
41. Xu X.-G., Tong D.-W., Wang Z.S., Zhang Q., Li Z.-C., Zhang K., Li W., Liu H.-J. Baculovirus virions displaying infectious bursal disease virus VP2 protein protect chickens against infectious bursal disease virus infection. Avian Dis. 2011, 55:223-229.
42. Ye C., Jia L., Sun Y., Hu B., Wang L., Lu X., Zhou J. Inhibition of antiviral innate immunity by birnavirus VP3 protein via blockage of viral double-stranded RNA binding to the host cytoplasmic RNA Detector MDA5. J. Virol. 2014, 88(19):11154-11165.
43. Zawistowski J.S., Nakamura K., Parker J.S., Granger D.A., Golitz B.T., Johnson G.L. MicroRNA 9-3p targets β1 integrin to sensitize claudin-low breast cancer cells to MEK inhibition. Mol. Cell. Biol. 2013, 33:2260-2274.
44. Zhou X., Wang D., Xiong J., Zhang P., Li Y., She R. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein. Vaccine 2010, 28:3990-3996.
45. Zuniga E., Hahm B., Oldstone M. Type I interferon during viral infections: multiple triggers for a multifunctional mediator. Interferon: The 50th Anniversary 2007, 337-357. Springer.